Literature DB >> 3806203

Surgical treatment of Cushing's disease.

W F Chandler, D E Schteingart, R V Lloyd, P E McKeever, G Ibarra-Perez.   

Abstract

The endocrinological, radiological, surgical, and pathological experience with 34 consecutive patients operated on for Cushing's disease is presented. Preoperative endocrine evaluation demonstrated that 19 patients had "typical" endocrine patterns for pituitary adrenocorticotropic hormone (ACTH)-dependent hypercortisolism and 11 had "atypical" testing. Pituitary pathology was found in 95% of the patients with typical preoperative endocrine testing but in only 55% of those with atypical testing. Eight of 34 preoperative computerized tomography scans demonstrated tumors, which correlated in all instances with the surgical findings. Microadenomas were removed from 25 patients, 22 of whom achieved postoperative remission of endocrine symptoms. Macroadenomas were found in three patients, only one of whom achieved remission after surgery. One patient had removal of an adenoma in the pharyngeal pituitary, and in another an ectopic lung carcinoid was excised; both of these patients were in postoperative remission. Four patients underwent transsphenoidal exploration but no definitive explanation was found for their hypercortisolism; these patients were not in remission. Immunohistochemical staining was performed on every specimen and all tumors showed excessive ACTH-secreting cells. A new rapid stain of the fibrovascular stroma is described.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806203     DOI: 10.3171/jns.1987.66.2.0204

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

2.  Stereotactic radiosurgery in pituitary adenomas: long-term single institution experience and role of the hypothalamic-pituitary axis.

Authors:  Kita Sallabanda; Sergey Usychkin; Fernando Puebla; José C Bustos; José A Gutiérrez-Diaz; Carmen Peraza; César Beltrán; Hugo Marsiglia; José Samblás
Journal:  J Radiosurg SBRT       Date:  2011

Review 3.  Stereotactic radiosurgery for pituitary adenomas: a review of the literature.

Authors:  Edward R Laws; Jason P Sheehan; Jonas M Sheehan; Jay Jagnathan; John A Jane; Rod Oskouian
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  Transsphenoidal surgery for Cushing disease: experience with 136 patients.

Authors:  Ivan Ciric; Jin-Cheng Zhao; Hongyan Du; James W Findling; Mark E Molitch; Roy E Weiss; Samuel Refetoff; William D Kerr; Joel Meyer
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

5.  Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.

Authors:  F Bakiri; S Tatai; R Aouali; M Semrouni; P Derome; F Chitour; M Benmiloud
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

6.  Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas.

Authors:  Chul Bum Cho; Hae Kwan Park; Won Il Joo; Chung Kee Chough; Kyung Jin Lee; Hyoung Kyun Rha
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

7.  Role of bilateral adrenalectomy in Cushing's disease.

Authors:  G Favia; M Boscaro; F Lumachi; D F D'Amico
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

8.  Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.

Authors:  I Jonathan Pomeraniec; Hideyuki Kano; Zhiyuan Xu; Brandon Nguyen; Zaid A Siddiqui; Danilo Silva; Mayur Sharma; Hesham Radwan; Jonathan A Cohen; Robert F Dallapiazza; Christian Iorio-Morin; Amparo Wolf; John A Jane; Inga S Grills; David Mathieu; Douglas Kondziolka; Cheng-Chia Lee; Chih-Chun Wu; Christopher P Cifarelli; Tomas Chytka; Gene H Barnett; L Dade Lunsford; Jason P Sheehan
Journal:  J Neurosurg       Date:  2017-10-27       Impact factor: 5.115

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.